Mukka Proteins Limited (MUKKA) - Net Assets
Based on the latest financial reports, Mukka Proteins Limited (MUKKA) has net assets worth Rs5.29 Billion INR (≈ $57.19 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs16.21 Billion ≈ $175.32 Million USD) and total liabilities (Rs10.92 Billion ≈ $118.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See debt-free asset ratio of Mukka Proteins Limited to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs5.29 Billion |
| % of Total Assets | 32.62% |
| Annual Growth Rate | 42.6% |
| 5-Year Change | 457.26% |
| 10-Year Change | N/A |
| Growth Volatility | 57.3 |
Mukka Proteins Limited - Net Assets Trend (2019–2026)
This chart illustrates how Mukka Proteins Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Mukka Proteins Limited market cap and net worth.
Annual Net Assets for Mukka Proteins Limited (2019–2026)
The table below shows the annual net assets of Mukka Proteins Limited from 2019 to 2026. Also explore Mukka Proteins Limited (MUKKA) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs5.29 Billion ≈ $57.19 Million |
+15.83% |
| 2025-03-31 | Rs4.57 Billion ≈ $49.37 Million |
+11.80% |
| 2024-03-31 | Rs4.08 Billion ≈ $44.16 Million |
+187.67% |
| 2023-03-31 | Rs1.42 Billion ≈ $15.35 Million |
+49.58% |
| 2022-03-31 | Rs948.89 Million ≈ $10.26 Million |
+35.70% |
| 2021-03-31 | Rs699.24 Million ≈ $7.56 Million |
+21.08% |
| 2020-03-31 | Rs577.51 Million ≈ $6.25 Million |
+30.96% |
| 2019-03-31 | Rs440.98 Million ≈ $4.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mukka Proteins Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs300.00 Million | 6.01% |
| Other Components | Rs4.69 Billion | 93.99% |
| Total Equity | Rs4.99 Billion | 100.00% |
Mukka Proteins Limited Competitors by Market Cap
The table below lists competitors of Mukka Proteins Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Amicorp FS (UK) PLC
LSE:AMIF
|
$87.50 Million |
|
New Delhi Television Limited
NSE:NDTV
|
$87.51 Million |
|
Maywufa Co Ltd
TW:1731
|
$87.52 Million |
|
FitLife Brands, Inc. Common Stock
NASDAQ:FTLF
|
$87.52 Million |
|
Apetit Oyj
HE:APETIT
|
$87.37 Million |
|
Builddirect.com Tehcnologies Inc
V:BILD
|
$87.35 Million |
|
LOT VACUUM Co. Ltd
KQ:083310
|
$87.34 Million |
|
Clipan Finance Indonesia Tbk
JK:CFIN
|
$87.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mukka Proteins Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 4,407,030,000 to 4,990,860,000, a change of 583,830,000 (13.2%).
- Net income of 520,580,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 3,269,999.
- Other factors increased equity by 59,980,001.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs520.58 Million | +10.43% |
| Other Comprehensive Income | Rs3.27 Million | +0.07% |
| Other Changes | Rs59.98 Million | +1.2% |
| Total Change | Rs- | 13.25% |
Book Value vs Market Value Analysis
This analysis compares Mukka Proteins Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.61x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.37x to 1.61x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | Rs1.47 | Rs26.93 | x |
| 2020-03-31 | Rs1.89 | Rs26.93 | x |
| 2021-03-31 | Rs2.22 | Rs26.93 | x |
| 2022-03-31 | Rs4.08 | Rs26.93 | x |
| 2023-03-31 | Rs6.07 | Rs26.93 | x |
| 2024-03-31 | Rs17.53 | Rs26.93 | x |
| 2025-03-31 | Rs14.70 | Rs26.93 | x |
| 2026-03-31 | Rs16.68 | Rs26.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mukka Proteins Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.43%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.59%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 3.25x
- Recent ROE (10.43%) is below the historical average (20.98%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 32.49% | 3.61% | 1.97x | 4.57x | Rs98.91 Million |
| 2020 | 23.30% | 2.48% | 1.82x | 5.18x | Rs75.21 Million |
| 2021 | 13.49% | 1.52% | 1.66x | 5.34x | Rs23.24 Million |
| 2022 | 26.95% | 3.16% | 1.95x | 4.37x | Rs152.26 Million |
| 2023 | 32.98% | 3.81% | 2.01x | 4.30x | Rs307.12 Million |
| 2024 | 17.69% | 5.08% | 1.47x | 2.38x | Rs304.43 Million |
| 2025 | 10.54% | 4.62% | 0.94x | 2.44x | Rs23.89 Million |
| 2026 | 10.43% | 3.59% | 0.89x | 3.25x | Rs21.49 Million |
Industry Comparison
This section compares Mukka Proteins Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $20,117,307,101
- Average return on equity (ROE) among peers: 15.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mukka Proteins Limited (MUKKA) | Rs5.29 Billion | 32.49% | 2.07x | $87.37 Million |
| ADF Foods Limited (ADFFOODS) | $1.59 Billion | 4.16% | 0.22x | $310.64 Million |
| Ajooni Biotech Limited (AJOONI) | $121.65 Million | 3.38% | 0.50x | $6.11 Million |
| Agro Tech Foods Limited (ATFL) | $4.86 Billion | 3.10% | 0.32x | $365.36 Million |
| Avanti Feeds Limited (AVANTIFEED) | $15.95 Billion | 21.73% | 0.18x | $1.14 Billion |
| Adani Wilmar Limited (AWL) | $104.44 Billion | 9.98% | 1.37x | $2.61 Billion |
| Bombay Burmah Trading Corporation Limited (BBTC) | $29.10 Billion | 13.27% | 0.76x | $1.14 Billion |
| Mrs. Bectors Food Specialities Limited (BECTORFOOD) | $4.69 Billion | 12.18% | 0.54x | $735.54 Million |
| Bikaji Foods International Limited (BIKAJI) | $8.21 Billion | 9.50% | 0.34x | $1.57 Billion |
| Britannia Industries Limited (BRITANNIA) | $25.86 Billion | 58.97% | 1.91x | $13.02 Billion |
| CCL Products (India) Limited (CCL) | $6.36 Billion | 21.15% | 0.33x | $1.53 Billion |
About Mukka Proteins Limited
Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; and ento meal, oil, and soil. It also provides insect meal, oil, and compost; and humic acid. The company's products are used for aqua feed, poultry feed, pet feed, EPADHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exp… Read more